ROODY DALBERIS: Open Payments
NPI 1508455643 · IRVINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 7 payments from 5 companies in 2025. Trend: 2023 $298 · 2024 $371 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $119 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Novo Nordisk Inc | 2 | $37 |
| Amgen Inc. | 1 | $16 |
| Neurelis, Inc. | 1 | $14 |
Products named: JARDIANCE, CAMZYOS, ELIQUIS, Ozempic, Repatha, VALTOCO.
Industry payments across NJ — which companies pay providers there.
